FDA to Use Ariana for Genomic Data Tools

The FDA will use Ariana Pharma's biomarker data mining technology to review and analyze data submitted through a voluntary data submission program.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.